Philippine Clinical Practice Guidelines for Periodic Health Examination: Screening for Hearing Disorders.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Carrillo Ryner Jose D, Salcedo Abigail S, Pascual V Jose Leonard R, Alcances Lina Rose A, Baltazar-Braganza Kathryn, Murillo Karl Jeffrey E, Cruz-Tantoco Marie Gene, Imbag Mark Dale S, Collante Ma Theresa M, Tan Charlotte Averill Y, Joson Marquis Von Angelo Syquio Go, Alonzo Ma Kriselda P, Adique Larissa Christia F, Andal-Saniano Abigael C, Catangay-Ombao Jaymilyn V, Cucueco Maria Teresita S, De Ramos Joanne Sebastiana M, Cruz Elmer M Dela, Lacuata Jan Alexeis C, Canceko-Llego Cindy, Ong Kimberly Mae C, Ramos Hubert D, Reyes-Quintos Maria Rina T, Ricalde Rosario R, Yarza Talitha Karisse L, Philippine Periodic Health Examination Task Force on Screening for Hearing Disorders
Аннотация
METHODS: Following the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach to CPG development recommended in the Department of Health Manual, the Task Force Steering Committee developed four key questions. The evidence review experts reviewed existing CPGs and appraised and summarized evidence. The multisectoral consensus panel reviewed the evidence summaries and developed recommendations during the en banc meeting. Three independent stakeholders reviewed the draft guidelines on the content, clarity, acceptability, applicability, and feasibility of the recommendations. Their feedback was taken into consideration by the steering committee before finalizing the CPG.
RESULTS: This CPG provides 10 recommendations based on four prioritized questions in the screening for hearing and vestibular disorders among apparently healthy children (from prenatal to school age) and adults.
CONCLUSION: The consensus panel recommended the screening for hearing and vestibular disorders in certain population groups, based on the available evidence, the burden of disease, the cost of the confirmatory testing, and its applicability to the population.